Twist Bioscience TWST
$103.32 −$8.30 (-7.44%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $105.01 +1.64%
Open$108.39
Prev close$111.62
Day range$101.00 – $108.50
Volume3.38M
Market cap$6.85B
P/E (TTM)–
Dividend yield–
TWST Stock News
Headlines matching Twist Bioscience or the TWST ticker, most recent first.
- Leerink Partners Maintains Twist Bioscience(TWST.US) With Buy Rating, Raises Target Price to $190 Positive
- Twist Bioscience(TWST.US) Officer Sells US$56.33 Million in Common Stock
- Form 144 | Twist Bioscience(TWST.US) Officer Proposes to Sell 44.68 Million in Common Stocks
- Form 144 | Twist Bioscience(TWST.US) Officer Proposes to Sell 9.31 Million in Common Stocks
- BWS Financial Maintains Twist Bioscience(TWST.US) With Sell Rating, Maintains Target Price $45
- Leerink Partners Maintains Twist Bioscience(TWST.US) With Buy Rating, Raises Target Price to $160 Positive
- BWS Financial Initiates Twist Bioscience(TWST.US) With Sell Rating, Announces Target Price $45
- Piper Sandler Maintains Twist Bioscience(TWST.US) With Buy Rating, Raises Target Price to $115 Positive
- William Blair Maintains Twist Bioscience(TWST.US) With Buy Rating
- TD Cowen Maintains Twist Bioscience(TWST.US) With Buy Rating, Raises Target Price to $115 Positive
- CCORF Maintains Twist Bioscience(TWST.US) With Buy Rating, Maintains Target Price $120
- Baird Maintains Twist Bioscience(TWST.US) With Buy Rating, Raises Target Price to $115 Positive
- Evercore Downgrades Twist Bioscience(TWST.US) to Hold Rating, Raises Target Price to $102 Mixed
- Leerink Partners Maintains Twist Bioscience(TWST.US) With Buy Rating, Maintains Target Price $110
- Leerink Partners Maintains Twist Bioscience(TWST.US) With Buy Rating, Raises Target Price to $110 Positive
No comments yet — be the first to weigh in on TWST.
Sign in to join the discussion.